This announcement is a separate document:
迪哲医药：华泰联合证券有限责任公司关于迪哲（江苏）医药股份有限公司使用部分超募资金永久补充流动资金及将理财收益和利息的核查意见
Dizal: Huatai United Securities Co., Ltd.'s verification opinion on Dighe (Jiangsu) Pharmaceutical Co., Ltd.'s use of part of the overfunded capital to permanently supplement working capital and financial management income and interest
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.